Select Page

Investors

26 Jan 2021

Successful IPO of MEDESIS PHARMA, a biotechnology pharmaceutical company, on Euronext Growth Paris® (ISIN: FR0010844464, MNEMO: ALMDP).

Visit the Investors section for more information